Manchester Capital Management’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,938
Closed -$52K 1083
2021
Q3
$52K Hold
1,938
0.01% 425
2021
Q2
$62K Hold
1,938
0.01% 366
2021
Q1
$68K Hold
1,938
0.01% 355
2020
Q4
$62K Hold
1,938
0.01% 353
2020
Q3
$61K Hold
1,938
0.01% 322
2020
Q2
$69K Hold
1,938
0.01% 337
2020
Q1
$56K Hold
1,938
0.01% 346
2019
Q4
$46K Hold
1,938
0.01% 374
2019
Q3
$35K Hold
1,938
﹤0.01% 393
2019
Q2
$30K Hold
1,938
﹤0.01% 420
2019
Q1
$44K Buy
1,938
+1,260
+186% +$28.4K 0.01% 421
2018
Q4
$30K Hold
678
﹤0.01% 392
2018
Q3
$22K Hold
678
﹤0.01% 418
2018
Q2
$30K Buy
678
+310
+84% +$12K ﹤0.01% 403
2018
Q1
$15K Hold
368
﹤0.01% 435
2017
Q4
$17K Buy
+368
New +$14.5K ﹤0.01% 418

Other funds holding PETS

Manchester Capital Management's PETS Position: Q4 2021 in Review

Manchester Capital Management sold out of PetMed Express (PETS) in Q4 2021, closing a stake of 1,938 shares — an estimated $52K sold.

Manchester Capital Management first reported a position in PETS in Q4 2017 and held it in 16 quarters. The position peaked at $69K in Q2 2020. 182 funds tracked by Wall St. Rank hold PETS as of Q4 2021.

  • Manchester Capital Management reported no remaining PetMed Express position as of Q4 2021 after selling out during the quarter.
  • Manchester Capital Management sold 1,938 PetMed Express shares in Q4 2021, an estimated $52K.
  • Manchester Capital Management first reported a position in PetMed Express in Q4 2017 and held it in 16 quarters.
  • Manchester Capital Management's PetMed Express position peaked at $69K in Q2 2020.
  • 182 funds tracked by Wall St. Rank held PetMed Express as of Q4 2021.

Based on Manchester Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.